(Q51168822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Oliver A Cornely

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

7

Peter G Pappas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Jose Vazquez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jan De Waele

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Robert Betts

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Coleman Rotstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Andrew J Ullmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

1 reference

20 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Mycoses

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

79-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

3 March 2020

cites work

1 reference

Pinpointing prognostic indicators of fungal infections in transplant patients

21 January 2018

1 reference

Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review

21 January 2018

1 reference

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

Attributable mortality of nosocomial candidemia, revisited

21 January 2018

1 reference

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

21 January 2018

1 reference

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance

21 January 2018

1 reference

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

21 January 2018

1 reference

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

21 January 2018

1 reference

Changing patterns and trends in systemic fungal infections

21 January 2018

1 reference

Candidaemia in Europe: epidemiology and resistance

21 January 2018

1 reference

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

21 January 2018

1 reference

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

21 January 2018

1 reference

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

21 January 2018

1 reference

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

21 January 2018

1 reference

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

21 January 2018

1 reference

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

21 January 2018

1 reference

Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital

21 January 2018

1 reference

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

21 January 2018

1 reference

Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies

21 January 2018

1 reference

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

21 January 2018

1 reference

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006

21 January 2018

1 reference

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

21 January 2018

1 reference

Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

21 January 2018

1 reference

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature

21 January 2018

1 reference

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

Changing spectrum of invasive candidiasis and its therapeutic implications

21 January 2018

1 reference

APACHE II: a severity of disease classification system

21 January 2018

1 reference

An evaluation of outcome from intensive care in major medical centers

21 January 2018

1 reference

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

Clinical and microbiological aspects of candidemia due toCandida parapsilosisin Brazilian tertiary care hospitals

21 January 2018

1 reference

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/MYC.12104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23786573%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference